Public Listings for Caprelsa

//Public Listings for Caprelsa

Public Listings for Caprelsa

Caprelsa (vandetanib) is indicated for the treatment of symptomatic or progressive Medullary thyroid cancer in adult patients with unresectable locally advanced or metastatic disease.

Alberta Health Services has put the listing on their Outpatient Cancer Drug Benefit Program website. https://www.albertahealthservices.ca/assets/programs/ps-1025651-drug-benefit-list.pdf

Other provinces are in negotiations for listings.

By | 2018-09-18T23:32:14+00:00 September 18th, 2018|Treatment News|Comments Off on Public Listings for Caprelsa

About the Author: